SNN

Smith & Nephew plc
D

SNN

35.490
USD
4.70
(15.26%)
مغلق
حجم التداول
0
الربح لكل سهم
2
العائد الربحي
2.11
P/E
38
حجم السوق
15,527,965,821
أصول ذات صلة
ABT
ABT
0.780
(0.60%)
130.730 USD
BAX
BAX
0.405
(1.80%)
22.850 USD
BDX
BDX
-2.030
(-1.13%)
176.860 USD
BSX
BSX
-1.907
(-1.79%)
104.840 USD
EW
EW
-0.850
(-1.06%)
79.200 USD
ILMN
ILMN
-0.680
(-0.69%)
97.750 USD
ISRG
ISRG
-6.32
(-1.31%)
476.76 USD
MDT
MDT
0.070
(0.08%)
89.660 USD
PODD
PODD
-6.85
(-2.38%)
280.86 USD
TMO
TMO
-0.22
(-0.05%)
466.49 USD
المزيد
الأخبار المقالات

العنوان: Smith & Nephew plc

القطاع: Healthcare
الصناعة: Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.